Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Toll-like Receptor Interference in Myeloid Dendritic Cells through Head and Neck Cancer

HENNING FRENZEL, BETTINA HOFFMANN, CARSTEN BROCKS, PETER SCHLENKE, RALPH PRIES and BARBARA WOLLENBERG
Anticancer Research November 2006, 26 (6B) 4409-4413;
HENNING FRENZEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BETTINA HOFFMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARSTEN BROCKS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER SCHLENKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RALPH PRIES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BARBARA WOLLENBERG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Barbara.Wollenberg{at}hno.uni-luebeck.de
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: In head and neck squamous cell carcinoma (HNSCC) the secretion of various immunosuppressive mediators contributes to large-scale effects on the immune functions. The influence of HNSCC on the Toll-like receptor (TLR) expression profiles of human myeloid dendritic cells (MDCs), which have been identified in human solid tumor tissue of the head and neck, was analysed. Materials and Methods: MDCs were isolated from peripheral blood by ‘magnetic bead separation’ and subsequently incubated with supernatants of HNSCC permanent cell lines. TLR expression profiles were investigated using flow cytometry and SDS-PAGE. Results: Human MDC from peripheral blood were found to express all human TLRs except TLR4 and TLR9. Incubation of MDC with supernatants of HNSCC resulted in an increased expression of TLR7. Conclusion: The data suggest an interference of TLR7 expression through HNSCC and provide novel evidence of TLR alterations as a potential tumor promoting event in head and neck cancer.

  • HNSCC
  • myeloid dendritic cell
  • TLR
  • immunomodulation

Footnotes

  • ↵* Both authors contributed equally to this work.

  • Received May 29, 2006.
  • Revision received August 31, 2006.
  • Accepted September 14, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 6B
November-December 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Toll-like Receptor Interference in Myeloid Dendritic Cells through Head and Neck Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Toll-like Receptor Interference in Myeloid Dendritic Cells through Head and Neck Cancer
HENNING FRENZEL, BETTINA HOFFMANN, CARSTEN BROCKS, PETER SCHLENKE, RALPH PRIES, BARBARA WOLLENBERG
Anticancer Research Nov 2006, 26 (6B) 4409-4413;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Toll-like Receptor Interference in Myeloid Dendritic Cells through Head and Neck Cancer
HENNING FRENZEL, BETTINA HOFFMANN, CARSTEN BROCKS, PETER SCHLENKE, RALPH PRIES, BARBARA WOLLENBERG
Anticancer Research Nov 2006, 26 (6B) 4409-4413;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation
  • Google Scholar

More in this TOC Section

  • Ginsenoside Rh4 Induces Apoptosis Through ROS-Mediated Fas Signaling in Human Nasopharyngeal Carcinoma NPC/HK1 Cells
  • Genome-wide Analysis Highlights rs4671908 and rs2238431 as Predictors of Survival in Nasopharyngeal Carcinoma
  • Implications of the Cuproptosis Protein SLC31A1 for the Immune Microenvironment and Temozolomide Sensitivity in Glioblastoma
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire